These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A high-throughput target-based screening approach for the identification and assessment of Smiejkowska N; Oorts L; Van Calster K; De Vooght L; Geens R; Mattelaer H-P; Augustyns K; Strelkov SV; Lamprecht D; Temmerman K; Sterckx YG-J; Cappoen D; Cos P Microbiol Spectr; 2024 Mar; 12(3):e0372323. PubMed ID: 38315026 [TBL] [Abstract][Full Text] [Related]
5. Development of potent chemical antituberculosis agents targeting Mycobacterium tuberculosis acetohydroxyacid synthase. Jung IP; Ha NR; Lee SC; Ryoo SW; Yoon MY Int J Antimicrob Agents; 2016 Sep; 48(3):247-58. PubMed ID: 27451857 [TBL] [Abstract][Full Text] [Related]
6. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship. Tomioka H Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755 [TBL] [Abstract][Full Text] [Related]
7. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis. Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494 [TBL] [Abstract][Full Text] [Related]
8. Strategies to Combat Multi-Drug Resistance in Tuberculosis. Singh V; Chibale K Acc Chem Res; 2021 May; 54(10):2361-2376. PubMed ID: 33886255 [TBL] [Abstract][Full Text] [Related]
9. Identification of new benzamide inhibitor against α-subunit of tryptophan synthase from Mycobacterium tuberculosis through structure-based virtual screening, anti-tuberculosis activity and molecular dynamics simulations. Naz S; Farooq U; Ali S; Sarwar R; Khan S; Abagyan R J Biomol Struct Dyn; 2019 Mar; 37(4):1043-1053. PubMed ID: 29502488 [TBL] [Abstract][Full Text] [Related]
11. High-throughput screening of compounds library to identify novel inhibitors against latent Mycobacterium tuberculosis using streptomycin-dependent Mycobacterium tuberculosis 18b strain as a model. Sharma S; Bhat R; Singh R; Sharma S; Wazir P; Singh PP; Vishwakarma RA; Khan IA Tuberculosis (Edinb); 2020 Sep; 124():101958. PubMed ID: 32791471 [TBL] [Abstract][Full Text] [Related]
12. A virtual screen discovers novel, fragment-sized inhibitors of Mycobacterium tuberculosis InhA. Perryman AL; Yu W; Wang X; Ekins S; Forli S; Li SG; Freundlich JS; Tonge PJ; Olson AJ J Chem Inf Model; 2015 Mar; 55(3):645-59. PubMed ID: 25636146 [TBL] [Abstract][Full Text] [Related]
13. Perspective: Challenges and opportunities in TB drug discovery from phenotypic screening. Manjunatha UH; Smith PW Bioorg Med Chem; 2015 Aug; 23(16):5087-97. PubMed ID: 25577708 [TBL] [Abstract][Full Text] [Related]
14. Small organic molecules targeting the energy metabolism of Mycobacterium tuberculosis. Urban M; Šlachtová V; Brulíková L Eur J Med Chem; 2021 Feb; 212():113139. PubMed ID: 33422979 [TBL] [Abstract][Full Text] [Related]
16. Cationic amphipathic D-enantiomeric antimicrobial peptides with in vitro and ex vivo activity against drug-resistant Mycobacterium tuberculosis. Lan Y; Lam JT; Siu GK; Yam WC; Mason AJ; Lam JK Tuberculosis (Edinb); 2014 Dec; 94(6):678-89. PubMed ID: 25154927 [TBL] [Abstract][Full Text] [Related]
17. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents. Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612 [TBL] [Abstract][Full Text] [Related]
20. Biological Profiling Enables Rapid Mechanistic Classification of Phenotypic Screening Hits and Identification of KatG Activation-Dependent Pyridine Carboxamide Prodrugs With Activity Against Chengalroyen MD; Jordaan A; Seldon R; Ioerger T; Franzblau SG; Nasr M; Warner DF; Mizrahi V Front Cell Infect Microbiol; 2020; 10():582416. PubMed ID: 33282750 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]